Skip to main content


04-09-2023 | Type 2 diabetes | News

New model predicts kidney disease progression risk in type 2 diabetes

Novel model for risk prediction of kidney disease progression and efficacy of SGLT2 inhibition in patients with type 2 diabetes.

22-06-2023 | Cardiovascular outcomes | News

Finerenone modifies CKD-associated CV risk in albuminuric type 2 diabetes

Finerenone modifies the risk for chronic kidney disease associated cardiovascular events in patients with type 2 diabetes and moderate-to-severe albuminuria, FIDELITY study findings indicate.

26-05-2023 | Type 2 diabetes | News

Common antidiabetic add-on therapies offer similar renal outcomes

Different antidiabetic medications commonly used in addition to metformin for type 2 diabetes have a similar effect on kidney function.

24-02-2023 | Risk factors | News

Mortality risk factors vary by age in type 2 diabetes

Hypertension has the largest impact on mortality risk in younger people with type 2 diabetes, whereas chronic kidney disease is a greater threat for older people, shows a population-based study.

17-01-2023 | Lifestyle interventions | News

Healthy lifestyle wards off type 2 diabetes microvascular complications

Real-world data from the UK Biobank show the value of a healthy lifestyle in people with type 2 diabetes hoping to avoid microvascular complications.

08-12-2022 | Dapagliflozin | News

Dapagliflozin may cut hospitalization risk in CKD

A post-hoc analysis of DAPA-CKD indicates that people taking dapagliflozin have a reduced risk for hospitalization, for causes not limited to cardiac or renal.

02-12-2022 | Nephropathy | News

CKD strongest determinant of post-MI prognosis in type 1 diabetes

The presence of chronic kidney disease has a large impact on the likelihood of people with type 1 diabetes dying after a myocardial infarction, show findings from the FinnDiane Study.

Close up of urinalysis with reagent strips

10-11-2022 | Nephropathy | News

‘Strong justification’ for individualized albuminuria screening in type 1 diabetes

Screening people with type 1 diabetes for albuminuria at intervals determined by their baseline albumin excretion rate and glycated hemoglobin level reduces the time spent with undetected kidney disease, show DCCT/EDIC data.